Neurocrine (NB3) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Neurocrine Biosciences (DE:NB3) have in its pipeline
Neurocrine DE:NB3 is currently developing the following drugs: Nbi-1065890, Nbi-1117570, Nbi-1117568, Nbi-1065845, Crinecerfont, Valbenazine, Nbi-1070770, Nbi-921352, Nbi-827104, Luvadaxistat, Nbi-1065846, Tak-831 Oral Tablet, [14C]Tak-831 Iv Infusion, [14C]Tak-831 Oral Suspension, Tak-653, Ketamine, Nbi-98854, Tak-831 T2, Tak-831 T3. These drug candidates are in various stages of clinical development as the company works toward FDA approval.